监测动态动脉弹性以减少心脏手术后血管麻痹综合征中去甲肾上腺素治疗时长:一项前瞻性随机试验
该研究为前瞻性、开放标签、随机试验,纳入心脏外科体外循环术后因血管麻痹综合征需要去甲肾上腺素治疗的患者,随机分为基于动态动脉弹性的算法干预组和对照组。主要终点为去甲肾上腺素治疗时长。纳入130例,意向性分析118例(干预组59例,对照组59例)。纳入后干预组去甲肾上腺素累积治疗时长较对照组更短[17 h(13-26)vs 39 h(19-58),P<0.001],去甲肾上腺素累积剂量和ICU住院时间也更低(P<0.05)。其他结局(脓毒症相关器官衰竭评分、中心静脉血氧饱和度、心律失常、动脉乳酸水平)组间无差异。
要点
- 在心脏手术后血管麻痹综合征患者中,基于动态动脉弹性的算法使去甲肾上腺素累积治疗时长从对照组39 h(19-58)缩短至干预组17 h(13-26)(P<0.001)。
- 干预组去甲肾上腺素累积剂量和ICU住院时间均低于对照组(P<0.05)。
- 两组在脓毒症相关器官衰竭评分、中心静脉血氧饱和度、心律失常和动脉乳酸水平方面无组间差异。
- 该算法未改变灌注参数,也未增加输液量。
适用人群与场景
- 心脏外科体外循环术后因血管麻痹综合征需要去甲肾上腺素治疗的患者。
研究设计与关键结果
- 研究类型为前瞻性、开放标签、随机试验;纳入130例,意向性分析118例(干预组59例,对照组59例)。
- 纳入时两组人口学特征、手术数据和先前去甲肾上腺素治疗时长无显著差异[5 h(4-10)vs 5 h(5-7),P=0.543]。
- 纳入后干预组去甲肾上腺素累积治疗时长较对照组更短[17 h(13-26)vs 39 h(19-58),P<0.001]。
- 干预组去甲肾上腺素累积剂量和ICU住院时间也低于对照组(P<0.05)。
- 其他结局(脓毒症相关器官衰竭评分、中心静脉血氧饱和度、心律失常、动脉乳酸水平)组间无差异。
证据类型、等级与局限
- 证据类型:前瞻性、开放标签、随机试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,基于动态动脉弹性的血流动力学算法与更短的去甲肾上腺素治疗时长和更短的ICU住院时间相关。
- 作者认为,使用该算法未改变灌注参数,也未增加输液量。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate the ability of an algorithm based on dynamic arterial elastance to decrease the duration of norepinephrine treatment.
METHODS: We performed a prospective, open-label, randomized study in patients requiring norepinephrine for vasoplegic syndrome after cardiac surgery with cardiopulmonary bypass. Patients were randomized to an algorithm-based intervention group or a control group. The primary outcome was the duration of norepinephrine treatment. The secondary outcomes included the total dose of norepinephrine, the length of stay (LOS) in the ICU, central venous oxygen saturation, arterial lactate levels, arrhythmia and diuresis.
RESULTS: Of 130 included patients, 118 were analysed on an intention-to-treat basis (intervention group: n = 59; control group: n = 59). On inclusion, the intervention and control groups did not differ significantly in terms of demographic characteristics, surgical data or the prior duration of norepinephrine treatment [5 h (4-10) vs. 5 h (5-7), respectively; P = 0.543]. The cumulative duration of norepinephrine treatment after inclusion was shorter in the intervention group than in the control group [17 h (13-26)] vs. 39 h (19-58), respectively; (P < 0.001). The cumulative dose of norepinephrine and the LOS in the ICU were also lower in the intervention group (P < 0.05). There were no intergroup differences for other outcomes (the sepsis-related organ failure score, central venous oxygen saturation, arrhythmia, and arterial lactate levels).
CONCLUSION: A haemodynamic algorithm based on dynamic arterial elastance was associated with a shorter duration of norepinephrine treatment and a shorter LOS in the ICU. Use of the algorithm did not alter perfusion parameters or increase the volume of fluid infused. ClinicalTrials.gov Identifier: NCT02479529.
参考来源
- Guinot PG, Abou-Arab O, Guilbart M, et al. Monitoring dynamic arterial elastance as a means of decreasing the duration of norepinephrine treatment in vasoplegic syndrome following cardiac surgery: a prospective, randomized trial. Intensive Care Med. 2017. PMID: 28120005. doi:10.1007/s00134-016-4666-z
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。